DV
Dividend Vision

UPC — Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc (UPC)

Total return is -99.8% over the past 5.4 years, 213.8 points behind SPY at 114.0%. Its deepest 1-year drawdown was 76.2%.

Universe Pharmaceuticals manufactures, markets, and distributes traditional Chinese medicine derivative products in China, including treatments for chronic health conditions, cold and flu medications, and various herbal remedies, along with biomedical drugs and dietary supplements distributed through pharmaceutical companies, hospitals, clinics, and drugstore chains. The company does not currently distribute dividends or other income to shareholders. This stock appeals primarily to equity investors seeking exposure to the Chinese pharmaceuticals and traditional medicine sector rather than income-focused investors.

UPC key facts

Asset type
Stock
Asset class
Equity
Inception date
03/23/2021
Last close
$5.65
Market cap
$2,814,999
Average volume
32365.0
Beta
1.462
Payout ratio
0.0
Forward P/E
0.0
EPS
$-8.07